Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is a time-honored national high-tech enterprise. In December 1999, the Zhangzhou Pharmaceutical Factory established in 1956 was restructured into Pien Tze Huang Pharmaceutical. In June 2003, the company was listed on the Shanghai Stock Exchange. After two additional issues and one allotment, the company has now issued 603 million shares. Currently, the company has 34 holding subsidiaries, 8 joint -stock companies and 4 industry funds with more than 2,100 employees.

The management team of Pien Tze Huang follows the company’s principles to inherit, innovate and develop. With a positive and brave attitude, we build national quality with the spirit of pursuing perfection to create a long-lasting well-known brand. The “One Core & Two Wings” health industry development strategy we adhere to takes traditional Chinese medicine and biological pharmacy as the core, regards health care medicine and health care food and functional drinks, special efficacy cosmetics and household chemicals as two wings, and considers medicine distribution as supplement. We are committed to building Pien Tze Huang into a first-class brand of health maintenance in China to provide quality services for more people.

  1. Core Products:

    Originating from an imperial secret recipe of the Ming Dynasty. Pien Tze Huang was listed as one of the national protected varieties of traditional Chinese medicine and it has unique curative effect on liver diseases and cancer and health care; the relevant traditional production techniques were also included in the national intangible cultural heritage list. Our products have been exported to all parts of the world and become a “Chinese Symbol” on the Maritime Silk Road. For more than 20 years, our export volume ranks No.1 among the country’s foreign trade single variety of Chinese patent medicine.

  2. The Glories of Pien Tze Huang:

    The Pien Tze Huang brand has remained in the Hurun brand list for many years; it has been rated as the No.1 brand of “Healthy China” hepatobiliary drugs for three consecutive years and won the top Chinese brand award “China Spectrum Award”. With a brand value of RMB 24.903 billion, it ranked second on the “Brand Value Ranking List of China Time-honored Brands for 2018”. In December 2017, with a brand value of RMB 35.048 billion, it was listed as one of the “2017 World’s 500 Most Influential Innovation Brands”. Chairman Liu Jianshun was awarded as the “Model Worker of Fujian Province for 2018” and the “2017-2018 National Outstanding Entrepreneur”.

  3. Business Performance:

    The annual compound growth rate of Pien Tze Huang’s main economic indicators exceeds 20%, which is more than twice of the growth rate of the National Strategic Plan for TCM Development, ranking at the top of the industry. The company was included in the list of China’s top 100 pharmaceutical companies, and won the titles of Demonstration Enterprise of China’s Intellectual Property Protection, Pilot Demonstration Enterprise of National and Provincial Brand Cultivation, and Quality Benchmark Enterprise in Fujian. It was rated as the most respected listed company by investors in the country and listed as one of the Top 100 Main Board Listed Companies in China.

    In 2017, Pien Tze Huang achieved operating revenue of RMB 3.714 billion, up 60.85% year-on-year; its total profits reached RMB 942 million, up 54.55 percent; the net profit was RMB 780 million, up 53.99%; the tax revenue was RMB 452 million, up 16.83% year-on-year. In the first quarter of 2018, the company realized an operating income of RMB 1.222 billion, up 42.06% year-on-year; its total profits reached RMB 384 million, up 47.31%; the net profit was RMB 326 million, up 48.34%; the tax revenue was RMB 145 million, up 91.16% from a year earlier.

  In the new era, Pien Tze Huang will adhere to the long-tested principles and make new achievements. Leading by the spirit of the 19th National Congress of the Communist Party of China, we will uphold, inherit and carry forward the historical mission of traditional Chinese medicine culture to promote the “One Core & Two Wings” health industry development strategy. The company will deepen its reform and innovation to provide better and more efficient products and services to the society. All in all, we are committed to building Pien Tze Huang into a leading brand in the massive health industry and making unremitting efforts to achieve the goal of becoming a “10 Billion Corporation”.

  • Ointment GMP workshop
  • Leading Domestic Level
    of Chinese Medicine Extract Workshop
    GMP Workshop
  • Soild Preparation
    GMP Workshop
  • Green Grass
  • Green Grass